ArticleInternational journal of cancer2022

Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand-foot syndrome.

Katie Watts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.